AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Medistim

Earnings Release • Feb 28, 2020

3662_rns_2020-02-28_243fd4eb-537b-4345-8afe-22f375fe1c7d.html

Earnings Release

Open in Viewer

Opens in native device viewer

4th quarter and preliminary year end financials for 2019 for Medistim ASA

4th quarter was the second best quarter ever and 2019 was record sales for a year. Sales for the quarter ended at MNOK 95.7 (MNOK 97.9), while sales for 2019 ended at MNOK 363.7 (MNOK 325.9), a growth of 11.6 %. Sales in USA increased with 20.3 % in 2019 while Europe had a strong 4th quarter with a 39.0 % growth in sales of own products.

Currency neutral sales of own products decreased with 6.8 % for the quarter. For 2019, currency neutral growth in sales of own products was 10.3%. EBIT for the quarter ended at MNOK 19.7 (MNOK 27.8). For 2019 EBIT ended at MNOK 89.8 (MNOK 74.0), a 21.3 % growth. Earnings per share ended at NOK 3.87 (NOK 3.14) a 23.3 % increase. The Board suggests a dividend of NOK 2.75 per share (NOK 2.25), a 22.2 % increase.